Administration of recombinant human IL-15 to patients with metastatic disease was safe and caused efflux of NK cells from the circulation within 30 min followed by massive hyperproliferation by 48 h and return to baseline up on cessation of IL-15 administration35. The gene discussed is IL15; the disease is metastatic neoplasm.